Core Viewpoint - The "Annual ESG Pioneer Award (Small and Medium Market Capitalization)" recognizes companies that balance economic efficiency with social responsibility, highlighting their contributions to environmental, social, and governance (ESG) practices [1][2]. Group 1: Award Recipients - Eight companies received the "Annual ESG Pioneer Award (Small and Medium Market Capitalization)": - Li Jin Technology (00558.HK) - Lianyi Rong Technology-W (09959.HK) - Mobi Development (00947.HK) - Qingci Games (06633.HK) - Tianlun Gas (01600.HK) - Tongrentang Technology (01666.HK) - Weimob Group (02013.HK) - Zhonghui Group (00382.HK) - The ranking is in alphabetical order and does not imply any hierarchy [1]. Group 2: Evaluation Criteria - The award is based on a combination of quantitative data analysis and expert review, ensuring a comprehensive evaluation of the companies' ESG efforts [1]. - The aim of the award is to identify green enterprises and advanced companies that excel in promoting ESG principles and pursuing high-quality sustainable development [1]. Group 3: Event Overview - The event "Technology Empowerment, Capital Breakthrough" was held online on December 22, where the prestigious list of outstanding companies was announced [1]. - The "Golden Award" aims to create a valuable reference for investors by ranking listed companies and unicorns across various stock exchanges, including Hong Kong, Shanghai, Shenzhen, New York, and NASDAQ [2].

Core Viewpoint - The Chengdu Xindu District Market Supervision Administration has initiated an investigation into Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. regarding the alleged misrepresentation of a product labeled as "99% Pure Antarctic Krill Oil" [1][3]. Group 1: Investigation and Findings - A joint investigation team has been established by provincial and municipal market supervision departments to look into the allegations against the company [1]. - The Shanghai Consumer Protection Commission has identified two main fraudulent behaviors by the involved companies: knowingly misrepresenting the product's phospholipid content and misleading marketing practices [4][6]. Group 2: Company Responses - Beijing Tongrentang Health Pharmaceutical Co., Ltd. has ordered the cessation of sales of the disputed product and is conducting a thorough review of the situation [6]. - The company has also announced legal actions against the involved parties for unauthorized use of its brand name, which misled consumers [7]. Group 3: Consumer Protection Actions - The Shanghai Consumer Protection Commission has urged the company to conduct a self-examination, apologize to consumers, recall the problematic products, and provide compensation [4][6]. - Beijing Tongrentang Group has expressed deep regret over the incident and is committed to ensuring consumer rights are protected [6][7].

Core Viewpoint - The investigation into the "Antarctic Krill Oil Gel Candy" by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. has revealed serious allegations of product misrepresentation and fraud, leading to regulatory scrutiny and potential legal consequences for the involved parties [1][6][7]. Group 1: Investigation and Regulatory Actions - The Chengdu New District Market Supervision Administration has established a joint investigation team to look into the allegations against Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. and has initiated a case against the company [1]. - The Shanghai Consumer Protection Committee has conducted tests on 15 popular Antarctic krill oil products, finding that one product from Beijing Tongrentang contained no actual krill oil, despite claims of high purity [3]. - The Shanghai Consumer Protection Committee has urged the involved companies to conduct self-examinations, apologize to consumers, recall the problematic products, and provide legal compensation [6]. Group 2: Company Responses and Accountability - Beijing Tongrentang Group has issued a public apology, expressing deep concern over the consumer rights violations and committing to a thorough investigation of the involved products [6][7]. - The company has mandated the immediate removal of the implicated products from the market and is pursuing legal action against the responsible parties for trademark infringement and misleading marketing practices [7]. - A special task force will be dispatched by Beijing Tongrentang to conduct a comprehensive review of the situation and hold accountable those responsible for the mismanagement and oversight failures [7].

【导读】同仁堂集团就南极磷虾油事件致歉：全面开展品牌清理行动 中国基金报记者 晨曦 同仁堂集团，公开致歉！ 12 月 20 日上午，北京同仁堂集团发布致歉声明。声明称，针对近日有关 " 南极磷虾油 " 的舆论关注，北京同仁堂集团高度重视、深感痛心，对因此给消费者造成的权益损害，向广 大消费者和社会各界致以最诚恳的歉意。 同仁堂集团立即开展零容忍品牌严管专项行动，已采取如下措施： 一、 派专项工作组到四川，对涉事产品开展全面深入核查，坚决一查到底。 二、 责令并监督涉事经销主体四川健康立即下架涉事产品，严格按照监管部门要求依法依规 对消费者进行赔偿。 三、 依法追究四川健康、哈博药业及相关电商平台的商标侵权等责任。对其违法使用 " 北京 同仁堂 " 字样，误导消费者判断，损害消费者合法权益的行为追究法律责任。 四、 对四川健康及其控股股东健康药业等单位在经营、管理、监督环节存在的问题开展问 责，严肃追究相关人员责任。 此外，同仁堂集团还表示，为进一步保护消费者权益，强化品牌保护责任，将开展以下工 作：全面排查品牌使用中的违法违规行为，对集团各级企业的品牌使用情况进行拉网式核 查。全面开展品牌清理行动，坚决清理 ...

Core Viewpoint - Tongrentang Technology Company utilizes the "Brilliant China" exhibition to revitalize its century-old brand, showcasing the depth of traditional Chinese medicine culture and its modern vitality [1][10]. Brand Communication Strategy - The company captures the emotional needs of modern consumers, creating a brand communication matrix that resonates deeply with both physical and emotional aspects of health [2]. - The emotional connection is emphasized through storytelling, such as the narrative around "36.5 degrees Celsius" representing both health and emotional warmth [5]. Product Focus and Health Philosophy - The company promotes its products like Beijing Tongrentang Cold Relief Granules, linking their efficacy to emotional support and everyday life experiences [5]. - The philosophy of "preventive treatment" is highlighted through products like Liuwei Dihuang Wan, which not only address health issues but also support a balanced lifestyle [7]. Brand Recognition and Industry Impact - The participation in the "Brilliant China" exhibition signifies national recognition of the company's brand strength and industry position, merging traditional wisdom with modern technology [10]. - The company's approach serves as a model for brand upgrading in the traditional Chinese medicine sector, contributing to the broader health consumption market [10]. Future Directions - The company aims to continue its commitment to traditional Chinese medicine while exploring innovative paths for development and enhancing product quality through technology [10]. - Plans include deepening the core product matrix, innovating communication strategies, and accelerating international expansion to showcase the unique charm of traditional Chinese medicine globally [10].

Core Viewpoint - The article highlights the alarming findings regarding the quality of Antarctic krill oil products, particularly focusing on a product marketed by Beijing Tongrentang, which was found to contain no phospholipids despite claims of high purity and content [4][6][9]. Group 1: Product Quality Issues - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was tested and found to have a phospholipid content of 0, contradicting its advertised claims of 43% [6][9]. - The product's distributor, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., and the manufacturer, Anhui Habao Pharmaceutical Co., Ltd., were implicated in the scandal, with the manufacturer admitting to not including the claimed Antarctic krill oil in production [12][13]. - The product was sold at approximately 60 yuan per bottle, while the production cost was only 3 to 3.7 yuan, raising questions about the pricing and quality of the product [14]. Group 2: Brand Trust and Reputation - The incident is part of a larger pattern of trust issues surrounding the Tongrentang brand, which has faced multiple controversies over product quality and misleading marketing practices [22][24]. - The article emphasizes that the trust erosion for a brand with over 350 years of history is detrimental, as each instance of compromised integrity undermines the brand's foundational values [33]. - The article calls attention to the broader implications for consumer confidence in health products, suggesting that such incidents can negatively impact overall consumption and market trust [29][30]. Group 3: Regulatory and Market Implications - The article points out the regulatory gaps and brand authorization issues that allow for such misleading products to enter the market, indicating a need for stricter oversight [32]. - The Shanghai Consumer Protection Commission is actively investigating the matter and has urged consumers to be cautious when purchasing health-related products [27]. - The article concludes that the presence of substandard products like the Antarctic krill oil not only harms consumer rights but also poses a risk to the growth of health consumption as a key driver of economic demand [28][29].

Core Points - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" claimed a phospholipid content of 43%, but actual tests showed it to be 0, indicating potential false advertising and consumer rights violations [2] - The distributor of the product is Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., while the manufacturer is Anhui Hab Pharmaceutical Co., Ltd. Beijing Tongrentang Health Pharmaceutical Co., Ltd. stated that the product was unauthorized and will pursue legal action against the involved companies [2] - The relationship between the companies is complex, with Beijing Tongrentang Health Pharmaceutical Co., Ltd. holding a 51% stake in Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., raising questions about accountability and the potential damage to the Tongrentang brand [2] Company and Industry Summary - The incident highlights issues of brand integrity and consumer trust within the health product industry, particularly for established brands like Beijing Tongrentang [2] - The Shanghai Consumer Protection Committee's involvement indicates regulatory scrutiny and the potential for broader implications for the industry regarding product labeling and consumer rights [2] - The situation raises concerns about the responsibilities of parent companies in overseeing the actions of their subsidiaries, especially in the context of product quality and marketing claims [2]

Core Viewpoint - A product claiming to be "99% pure Antarctic krill oil" from "Beijing Tongrentang" was found to contain "0" krill oil, raising concerns about misleading marketing practices and consumer protection [1][3][12]. Group 1: Product Misrepresentation - The Shanghai Consumer Protection Commission tested 15 popular Antarctic krill oil products and discovered that the product in question had no actual krill oil content, despite claims of 43% phospholipid content [1][3]. - The manufacturer, Anhui Habao Pharmaceutical Co., admitted that the product was customized by the distributor, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., and did not contain the claimed krill oil [4][8]. - The product was sold at a price of 60 yuan per bottle, while the manufacturer's cost was only 3 to 3.7 yuan, raising questions about the legitimacy of the pricing and the quality of the ingredients [4][11]. Group 2: Misleading Branding - The packaging prominently featured "Beijing Tongrentang," which misled consumers into believing it was a product directly from the well-known brand, while it was actually from a different company [4][7]. - The product's branding utilized a design that closely resembled the core trademark of Beijing Tongrentang, creating a deceptive impression of authenticity [7][19]. - The distributor claimed that misleading packaging decisions were made by the manufacturer, while the manufacturer stated that the packaging was designed according to the distributor's specifications, indicating a shared responsibility for the misleading marketing [8][11]. Group 3: Broader Industry Implications - The incident is not isolated; there is a larger trend of "borderline" products using the Tongrentang name to mislead consumers, with similar products also found on e-commerce platforms [12][18]. - The Shanghai Consumer Protection Commission urged the distributor to conduct a self-examination, apologize to consumers, and recall the problematic products [19][20]. - Beijing Tongrentang Health Pharmaceutical Co. announced that it would stop the distribution of the implicated product and initiate legal action against the responsible parties for unauthorized use of its name [19][20].

Core Viewpoint - The Shanghai Consumer Rights Protection Committee has accused Anhui Habio Pharmaceutical Co., Ltd. and Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. of potential fraud regarding the "99% High Purity Antarctic Krill Oil" product, highlighting serious discrepancies between product claims and actual content [1] Group 1: Company Actions - Anhui Habio Pharmaceutical admitted that the product did not contain the claimed "Antarctic krill oil" during production [1] - Beijing Tongrentang (Sichuan) Health claimed ignorance of the alleged fraudulent behavior and distanced itself from responsibility during the inquiry [1] Group 2: Investigation Findings - The Shanghai Consumer Rights Protection Committee found evidence of intentional fraud, noting that the product falsely claimed a phospholipid content of 43% while lacking the advertised ingredient [1] - The investigation revealed deliberate misleading practices in product packaging and marketing [1] Group 3: Recommendations - The Shanghai Consumer Rights Protection Committee has recommended that Beijing Tongrentang (Sichuan) Health conduct a self-examination, issue an apology for the infringement, recall the problematic products, and provide legal compensation [1]

Group 1 - The Shanghai Consumer Protection Commission has disclosed that it has interviewed distributors and manufacturers regarding issues related to Antarctic krill oil products [1] - Anhui Hab Pharmaceutical Co., Ltd. admitted that the products in question did not contain the claimed "Antarctic krill oil" during the production process [1] - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. evaded responsibility during the interview, claiming ignorance of the alleged fraudulent behavior [1] Group 2 - The Shanghai Consumer Protection Commission has urged Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. to conduct a self-examination and inform consumers of the situation [2] - The commission has requested that the company sincerely apologize to consumers for infringing on their rights [2] - The commission has also called for a recall of the problematic products and for the companies involved to process refunds and compensations for consumers [2]